Loose skin after Ozempic: why it happens, what helps

Key takeaways

• Loose skin after a GLP-1 is not the medicine attacking your skin. It is what large weight loss does: the collagen and elastin that let skin snap back get stretched and worn down, so it does not fully retract .
• The trigger is the size of the loss, and GLP-1 loss is large: about 15% of body weight on semaglutide (STEP-1) and about 21% on tirzepatide (SURMOUNT-1), the kind of drop that used to come mainly from bariatric surgery .
• How much loose skin you end up with depends on the amount and speed of the loss, your age, genetics, nutrition, and sun history, not on which pen you used .
• The lever with real evidence is keeping muscle. Resistance training beats cardio for holding onto lean mass during weight loss, and enough protein protects it further .
• Firming creams are subtle at best and cannot lift loose skin; lasers and radiofrequency tighten modestly; a large amount of hanging skin only comes off with body-contouring surgery .

What actually helps, and what is mostly a waste of money

It is the size of the loss, not the drug

Here is the part that reframes the whole worry. The medicine is not reaching down and loosening your skin. Big weight loss is. Carry extra weight for a while and the skin stretches to cover it, and the collagen and elastin that let skin spring back get worn down in the process.

A plastic-surgery analysis of skin after major weight loss puts the mechanism plainly: loose skin usually happens because of damage to collagen and elastin, which leaves the skin with no good way to retract once the weight is gone . That is also why it shows up after bariatric surgery and crash diets, not just GLP-1s.

And GLP-1 weight loss is not small. In the pivotal trials, semaglutide averaged about 15% of body weight (STEP-1) and tirzepatide about 21% (SURMOUNT-1) . That is the size of loss that used to come mostly from surgery, which is exactly the group the loose-skin research studied. The drug did not change your skin. It made a surgery-sized weight loss something you can do with a weekly shot.

Why two people lose the same weight and get different skin

Skin laxity is not one-size-fits-all, because it has a list of inputs. The same analysis flags the usual ones: how much and how fast you lose, your age, your genetics, your nutrition, and how much sun your skin has logged over the years .

Younger skin with more elastin left in it tends to bounce back better. Skin that spent decades stretched, or out in the sun, has less spring to give. None of that is about the brand in the pen, which is the same reason Ozempic face lands harder on older faces. It is biology and timing doing the sorting.

Big skin folds are not just a vanity problem

It is easy to file loose skin under looks, but large folds can be a genuine nuisance. The American Academy of Dermatology, listing the skin changes people notice on GLP-1 drugs, includes loose skin that folds on itself and rubs into rashes where skin meets skin .

The surgical literature describes the same thing in heavier cases: pain, irritation, and intertrigo (the rash that forms in warm, damp skin folds) under large flaps of redundant skin . So if the skin is far enough along to chafe or break down, that is a medical reason to deal with it, not only a cosmetic one.

The levers that are actually in your hands

• Build and keep muscle. This is the one with trial backing. A European obesity working group concluded that resistance training, more than cardio, blunts the lean-mass loss that comes with dieting, and pairing it with enough protein protects muscle further . Muscle under the skin gives it something to drape over, and you keep the metabolic upside too. (More in GLP-1 and muscle loss and body recomposition vs weight loss.)
• Do not sprint the last stretch. Since the size and speed of the loss is the trigger, easing the pace gives skin a bit more time to keep up. It is the same lever that helps with the face.
• Drink your fluids. The least exciting item on the list, but the AAD's own GLP-1 guidance lands on staying well hydrated to keep skin in better shape .
• Give it time, within limits. Skin keeps adjusting for months after the weight settles, but once collagen and elastin are stretched past their limit, there is only so far it springs back .

When surgery is the honest answer

For a lot of people the skin tightens enough that they stop thinking about it. For others, especially after a very large loss, there is real hanging skin left over. This is where it helps to be blunt about what the menu can and cannot do.

• Creams and firming lotions: the AAD does not soften it. If you want facelift-from-a-jar results, you will be disappointed, because a cream cannot reach deep enough to lift loose skin, and any effect is subtle at best .
• Lasers and radiofrequency: these do something. Laser resurfacing can tighten skin, often better than other nonsurgical options, and radiofrequency gives gradual tightening over about six months. But the same AAD guidance is clear that if you already have a lot of sagging skin, tightening procedures may not help much .
• Surgery: for large amounts of redundant skin, body-contouring surgery (a tummy tuck, an arm or thigh lift, and the rest) is the established fix. The plastic-surgery literature treats it as the main way to actually remove the excess, not an optional cosmetic add-on .

The honest bottom line

Loose skin after a GLP-1 is real, it is the weight loss and not the molecule, and how much you get is mostly set by how much you lose and what your skin walked in with. You cannot promise yourself zero. You can keep muscle, hold a sane pace, and skip the creams that promise a facelift. A large amount of excess skin is a surgical problem, and a smaller amount usually settles better than people fear at month three.

None of that is a reason to want the weight back. It is a reason to know the trade going in, and to spend your effort on the lever that actually works.

For research and educational purposes only. Not medical advice.

pepSmart has not commissioned independent clinical review of this article.

More on how we write and source these pieces: Editorial process and contributor disclosure and Sourcing posture.

Spot an error? Email corrections via /about.

Sources: 7 entries, five peer-reviewed journal sources (two NEJM obesity trials plus plastic-surgery and exercise-medicine reviews) and two American Academy of Dermatology patient references, acknowledged inline. Last reviewed 2026-06-21.

Related tools

• Tirzepatide dose calculator - Run tirzepatide-focused vial draw math.
• GLP-1 conversion calculator - Convert a GLP-1 mg dose to U-100 units and ml.
• GLP-1 ramp planner - Preview a linear educational dose-step table.
• Peptide half-life calculator - Estimate single-dose decay from cited half-life constants.
• PK simulator overview - Public overview of the Pro pharmacokinetic simulator.
• Body-recomp simulator overview - Public overview of the Pro body-recomposition simulator.